相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
Katarina Sebekova et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity
J. M. Brix et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease
Amir Tirosh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse
Hiroki Ueno et al.
ATHEROSCLEROSIS (2010)
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes
Naoto Katakami et al.
ATHEROSCLEROSIS (2009)
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Katarina Sebekova et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OBESITY (2009)
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population
Giuseppe Danilo Norata et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
The Metabolic Syndrome
Marc-Andre Cornier et al.
ENDOCRINE REVIEWS (2008)
RAGE and soluble RAGE: Potential therapeutic targets for cardiovascular diseases
Hidenori Koyama et al.
MOLECULAR MEDICINE (2007)
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
Giuseppina Basta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
H Koyama et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Divergent pathways of gene express ton are activated by the RAGE ligands S100b and AGE-BSA
JV Valencia et al.
DIABETES (2004)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)